(BMRN) Biomarin Pharmaceutical Weekly charts technical analysis
(BMRN) Biomarin Pharmaceutical Weekly charts technical analysis Weekly analysis of Biomarin Pharmaceutical | Buy/Sell Biomarin Pharmaceutical
Biomarin Pharmaceutical trades in USA in Health Care sector.
10 day averaged volume of Biomarin Pharmaceutical is 1895307
Date | Closing Price | Open | High | Low | Volume |
08 Wed Oct 2025 | 54.69 | 55.98 | 56.50 | 54.18 | 4.204 Mn |
03 Fri Oct 2025 | 55.43 | 53.76 | 56.00 | 53.19 | 10.077 Mn |
26 Fri Sep 2025 | 53.85 | 54.35 | 54.70 | 52.47 | 10.047 Mn |
19 Fri Sep 2025 | 54.36 | 54.25 | 55.52 | 52.94 | 13.381 Mn |
12 Fri Sep 2025 | 54.09 | 57.50 | 57.77 | 54.05 | 9.487 Mn |
05 Fri Sep 2025 | 57.77 | 58.40 | 59.79 | 55.99 | 7.002 Mn |
29 Fri Aug 2025 | 58.27 | 57.54 | 58.35 | 57.30 | 1.27 Mn |
29 Fri Aug 2025 | 58.27 | 58.88 | 58.94 | 57.15 | 8.152 Mn |
22 Fri Aug 2025 | 58.58 | 57.68 | 58.85 | 57.16 | 7.951 Mn |
15 Fri Aug 2025 | 57.54 | 56.92 | 59.09 | 56.45 | 10.396 Mn |
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.97 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.97 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.